In inflammatory bowel disease (IBD), Tollip overexpression in peritoneal macrophages inhibits LPS-induced production of pro-inflammatory cytokines and increases anti-inflammatory cytokines, demonstrating the role of Tollip in macrophage polarization (179). Here, TOLLIP is linked to inflammatory bowel disease.